An innovative portal for rare genetic diseases research: The semantic Diseasecard

Advances in "omics" hardware and software technologies are bringing rare diseases research back from the sidelines. Whereas in the past these disorders were seldom considered relevant, in the era of whole genome sequencing the direct connections between rare phenotypes and a reduced set of genes are of vital relevance. This increased interest in rare genetic diseases research is pushing forward investment and effort towards the creation of software in the field, and leveraging the wealth of available life sciences data. Alas, most of these tools target one or more rare diseases, are focused solely on a single type of user, or are limited to the most relevant scientific breakthroughs for a specific niche. Furthermore, despite some high quality efforts, the ever-growing number of resources, databases, services and applications is still a burden to this area. Hence, there is a clear interest in new strategies to deliver a holistic perspective over the entire rare genetic diseases research domain. This is Diseasecard's reasoning, to build a true lightweight knowledge base covering rare genetic diseases. Developed with the latest semantic web technologies, this portal delivers unified access to a comprehensive network for researchers, clinicians, patients and bioinformatics developers. With in-context access covering over 20 distinct heterogeneous resources, Diseasecard's workspace provides access to the most relevant scientific knowledge regarding a given disorder, whether through direct common identifiers or through full-text search over all connected resources. In addition to its user-oriented features, Diseasecard's semantic knowledge base is also available for direct querying, enabling everyone to include rare genetic diseases knowledge in new or existing information systems. Diseasecard is publicly available at http://bioinformatics.ua.pt/diseasecard/.

[1]  José Luís Oliveira,et al.  Using biomedical networks to prioritize gene–disease associations , 2011 .

[2]  José Luís Oliveira,et al.  BeCAS: biomedical concept recognition services and visualization , 2013, Bioinform..

[3]  B. Urbero,et al.  Utilisation d’un annuaire des services spécialisés et orientation dans le système de soins: l’exemple d’Orphanet dans les maladies rares , 2006 .

[4]  Arrigo Schieppati,et al.  Why rare diseases are an important medical and social issue , 2008, The Lancet.

[5]  Ian Horrocks,et al.  RDFS(FA) and RDF MT: Two Semantics for RDFS , 2003, SEMWEB.

[6]  Wu Xu,et al.  Using ICD-9-CM Codes in Hospital Claims Data to Detect Adverse Events in Patient Safety Surveillance , 2008 .

[7]  José Luís Oliveira,et al.  Towards knowledge federation in biomedical applications , 2011, I-Semantics '11.

[8]  José Luís Oliveira,et al.  WAVe: web analysis of the variome , 2011, Human mutation.

[9]  Jeroen F. J. Laros,et al.  LOVD v.2.0: the next generation in gene variant databases , 2011, Human mutation.

[10]  J. Stausberg,et al.  Identification of adverse drug events: the use of ICD-10 coded diagnoses in routine hospital data. , 2010, Deutsches Arzteblatt international.

[11]  Sören Auer,et al.  The emerging web of linked data , 2011, ISWSA '11.

[12]  Hans-Dieter Pohlenz,et al.  PhenomicDB: a multi-species genotype/phenotype database for comparative phenomics , 2005, Bioinform..

[13]  Robert D. Finn,et al.  New developments in the InterPro database , 2007, Nucleic Acids Res..

[14]  Nicole Tourigny,et al.  Bio2RDF: Towards a mashup to build bioinformatics knowledge systems , 2008, J. Biomed. Informatics.

[15]  K Henriksen,et al.  Using ICD-9-CM Codes in Hospital Claims Data to Detect Adverse Events in Patient Safety Surveillance -- Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 1: Assessment) , 2008 .

[16]  Adam Hunter,et al.  A modular approach to disease registry design: Successful adoption of an internet‐based rare disease registry , 2012, Human mutation.

[17]  Patrick Ruch,et al.  Mapping proteins to disease terminologies: from UniProt to MeSH , 2008, BMC Bioinformatics.

[18]  Cathy H. Wu,et al.  The Universal Protein Resource (UniProt) , 2006, Nucleic Acids Research.

[19]  Carol A. Bocchini,et al.  A new face and new challenges for Online Mendelian Inheritance in Man (OMIM®) , 2011, Human mutation.

[20]  Cédrick Fairon,et al.  Annotation analysis for testing drug safety signals using unstructured clinical notes , 2012, J. Biomed. Semant..

[21]  F. Walker.  Huntington's disease , 2007, The Lancet.

[22]  Alexander Münchau,et al.  Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY , 2011, PLoS currents.

[23]  H. Deng,et al.  Improved Detection of Rare Genetic Variants for Diseases , 2010, PloS one.

[24]  M. Orth.  Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[25]  B. Urbero,et al.  [Use of a directory of specialized services and guidance in the healthcare system: the example of the Orphanet database for rare diseases]. , 2006, Revue d'epidemiologie et de sante publique.

[26]  V Maojo,et al.  Grid Requirements for the Integration of Biomedical Information Resources for Health Applications , 2005, Methods of Information in Medicine.

[27]  M. Schuemie,et al.  Combining electronic healthcare databases in Europe to allow for large‐scale drug safety monitoring: the EU‐ADR Project , 2011, Pharmacoepidemiology and drug safety.

[28]  José Luís Oliveira,et al.  COEUS: “semantic web in a box” for biomedical applications , 2012, Journal of Biomedical Semantics.

[29]  C E Lipscomb,et al.  Medical Subject Headings (MeSH). , 2000, Bulletin of the Medical Library Association.

[30]  David S. Goodsell,et al.  The RCSB Protein Data Bank: new resources for research and education , 2012, Nucleic Acids Res..

[31]  Marian DiFiglia,et al.  Huntington Disease , 1998 .

[32]  John Mylopoulos,et al.  The Semantic Web - ISWC 2003 , 2003, Lecture Notes in Computer Science.

[33]  Surajit Chaudhuri,et al.  An overview of data warehousing and OLAP technology , 1997, SGMD.

[34]  José Luís Oliveira,et al.  COEUS: a semantic web application framework , 2011, SWAT4LS.

[35]  Alan F. Scott,et al.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..

[36]  José Luís Oliveira,et al.  GeNS: a Biological Data Integration Platform , 2009 .

[37]  Ahv Schapira,et al.  Neurology and clinical neuroscience , 2007 .

[38]  Pedro Lopes,et al.  A semantic web application framework for health systems interoperability , 2011, MIXHS '11.

[39]  O. Michael.  F02 Observing Huntington's disease (HD): the European Huntington's Disease Network's REGISTRY , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[40]  Maja Milicic Brandt,et al.  Mapping Orphanet Terminology to UMLS , 2011, AIME.

[41]  Shuangxi Liu,et al.  Data Updating and Query in Real-Time Data Warehouse System , 2008, 2008 International Conference on Computer Science and Software Engineering.

[42]  E. McCusker,et al.  Huntington's disease , 2010, The Lancet.

[43]  S. Sai Satyanarayana Reddy,et al.  Advanced Techniques for Scientific Data Warehouses , 2009, 2009 International Conference on Advanced Computer Control.

[44]  Jürgen Stausberg,et al.  Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data , 2011, BMC health services research.

[45]  Stuart Weibel,et al.  The Dublin Core: A Simple Content Description Model for Electronic Resources , 2005 .

[46]  C. Pasquier.  Biological data integration using Semantic Web technologies. , 2008, Biochimie.

[47]  Kei-Hoi Cheung,et al.  Advancing translational research with the Semantic Web , 2007, BMC Bioinformatics.

[48]  Amos Bairoch,et al.  PROSITE, a protein domain database for functional characterization and annotation , 2009, Nucleic Acids Res..

[49]  Hong-Wen Deng,et al.  Efficient Utilization of Rare Variants for Detection of Disease-Related Genomic Regions , 2010, PloS one.

[50]  Enrique Seoane-Vazquez,et al.  Incentives for orphan drug research and development in the United States , 2008, Orphanet journal of rare diseases.

[51]  José Luís Oliveira,et al.  Gimli: open source and high-performance biomedical name recognition , 2013, BMC Bioinformatics.

[52]  P. Stenson,et al.  Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics , 2010, Human mutation.

[53]  V. Caviness.  Huntington's Disease , 1985, Developmental medicine and child neurology.

[54]  José Luís Oliveira,et al.  From the salivary proteome to the OralOme: comprehensive molecular oral biology. , 2012, Archives of oral biology.

[55]  B. Fadeel,et al.  A journey of hope: lessons learned from studies on rare diseases and orphan drugs , 2006, Journal of internal medicine.

[56]  Stephen P Gardner,et al.  Ontologies and semantic data integration. , 2005, Drug discovery today.

[57]  J. Aronson,et al.  Rare diseases and orphan drugs. , 2006, British journal of clinical pharmacology.

[58]  J. Oliveira,et al.  The EU‐ADR Web Platform: delivering advanced pharmacovigilance tools , 2013, Pharmacoepidemiology and drug safety.

[59]  G. van Ommen,et al.  Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading‐frame rule , 2006, Muscle & nerve.

[60]  José Luís Oliveira,et al.  DiseaseCard: A Web-Based Tool for the Collaborative Integration of Genetic and Medical Information , 2004, ISBMDA.